Testing effectiveness (Phase 2)WithdrawnNCT06657885
What this trial is testing
CAbotégravir LENacapavir DUal Long Acting
Who this might be right for
HIV1 InfectionMulti-treated Patients Who Have Received Multiple Lines of Antiretroviral TreatmentCABOTEGRAVIR+2 more
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba